Using a Transwell chemotaxis assay in a serum-free medium, Bajetto et al. found that the migration of human U87-MG GBM cells increased significantly in a dose-dependent manner with CXCL12 at concentrations ranging from 1 to 50 ng/mL. This evidence concerns the gene CXCL12 and glioblastoma.